Document 3133 DOCN M94A3133 TI Envelope V2 and V3 regions in circulating HIV-1 from patients with SI-variants. DT 9412 AU Telenti A; Grunow R; Deiss V; Bernasconi C; Matter L; von Overbeck J; Univ. of Berne, Switzerland. SO Int Conf AIDS. 1994 Aug 7-12;10(1):146 (abstract no. PB0009). Unique Identifier : AIDSLINE ICA10/94369442 AB BACKGROUND: SI phenotype may result from selection of a minority species. To evaluate this possibility, we studied match serum and MT-2 culture supernatant. The V2 and V3 of gp120, known determinants of a SI phenotype, were sequenced to establish how accurately cultured SI isolates reflect the circulating species in vivo. M&M: Samples from 14 patients were evaluated by culture in MT-2 cells, and sequencing of env from multiple clones obtained from culture supernatant and corresponding sera. A SI genotype was defined as presence of elongation of the V2 hypervariable region and/or increase in positive charge of the V3 loop. RESULTS: five groups were defined: TABULAR DATA, SEE ABSTRACT VOLUME. CONCLUSIONS: 1) V2 and/or V3 SI-genotype was always present in culture isolates exhibiting a SI phenotype. 2) The characteristics of V2 in culture--but not V3--reflected what was found in serum in most patients. 3) Only 3 patients exhibited a fully homogeneous population of SI-genotype variants in vivo and in vitro. Whether these patients experience a different clinical evolution, and the possibility that MT-2 assays not only select minority strains, but allow the outgrowth of variants not present in vivo need further assessment. DE Acquired Immunodeficiency Syndrome/*MICROBIOLOGY Cell Line Gene Products, env/BIOSYNTHESIS/*GENETICS *Genes, env Genotype Human HIV-1/*GENETICS/*ISOLATION & PURIF Phenotype Variation (Genetics) MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).